Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Jun 15;42(13):2226-2240.
doi: 10.1002/sim.9720. Epub 2023 Apr 17.

Studentized permutation method for comparing two restricted mean survival times with small sample from randomized trials

Affiliations

Studentized permutation method for comparing two restricted mean survival times with small sample from randomized trials

Marc Ditzhaus et al. Stat Med. .

Abstract

Recent observations, especially in cancer immunotherapy clinical trials with time-to-event outcomes, show that the commonly used proportional hazard assumption is often not justifiable, hampering an appropriate analysis of the data by hazard ratios. An attractive alternative advocated is given by the restricted mean survival time (RMST), which does not rely on any model assumption and can always be interpreted intuitively. Since methods for the RMST based on asymptotic theory suffer from inflated type-I error under small sample sizes, a permutation test was proposed recently leading to more convincing results in simulations. However, classical permutation strategies require an exchangeable data setup between comparison groups which may be limiting in practice. Besides, it is not possible to invert related testing procedures to obtain valid confidence intervals, which can provide more in-depth information. In this paper, we address these limitations by proposing a studentized permutation test as well as respective permutation-based confidence intervals. In an extensive simulation study, we demonstrate the advantage of our new method, especially in situations with relatively small sample sizes and unbalanced groups. Finally, we illustrate the application of the proposed method by re-analyzing data from a recent lung cancer clinical trial.

Keywords: hazard ratio; permutation methods; restricted mean survival time; survival analysis; time-to-event outcomes.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest

The authors declare no potential conflict of interests.

Figures

FIGURE 1
FIGURE 1
The survival functions of the 9 different settings from Section 3 under the null hypothesis as well as under the alternative μ2=1.5+μ1 (see A and B) and the survival functions for the three different censoring scenarios (see C)
FIGURE 2
FIGURE 2
Coverage in % (nominal level α=5%) of the confidence intervals based on the asymptotic approximation (Asy), the empirical likelihood ratio (ELR) and the studentized permutation approach with the regenerating strategy (Perm I) as well as with the horizontal extension of the permuted Kaplan–Meier curves (Perm II), respectively. The dashed, horizontal lines represent the binomial 95%-confidence interval [94.4%, 95.6%]
FIGURE 3
FIGURE 3
Kaplan–Meier curves of the reconstructed data

Similar articles

Cited by

References

    1. Trinquart L, Jacot J, Conner S, Porcher R. Comparison of treatment effects measured by the hazard ratio and by the ratio of restricted mean survival times in oncology randomized controlled trials. Journal of Clinical Oncology 2016; 34(15): 1813–1819. - PubMed
    1. Mick T, Chen TT. Statistical challenges in the design of late-stage cancer immunotherapy studies. Cancer Immunology Research 2015; 3(12): 1292–1298. - PubMed
    1. Alexander B, Schoenfeld J, Trippa L. Hazards of hazard ratios-deviations from model assumptions in immunotherapy. The New England Journal of Medicine 2018; 378(12): 1158–1159. - PubMed
    1. Zittoun R, Mandelli F, Willemze R, et al. Autologous or allogeneic bone marrow transplantation compared with intensive chemotherapy in acute myelogenous leukemia. New England Journal of Medicine 1995; 332(4): 217–223. - PubMed
    1. Scott B, Pasquini M, Logan B, et al. Myeloablative versus reduced-intensity hematopoietic cell transplantation for acute myeloid leukemia and myelodysplastic syndromes. Journal of Clinical Oncology 2017; 35(11): 1154. - PMC - PubMed

Publication types

LinkOut - more resources